Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathway
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Yi He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Neuroblastoma, N-Myc Proto-Oncogene Protein, Proto-Oncogene Proteins c-akt, Homeodomain Proteins. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tongji Hospital, Huazhong University of Science and Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Neuroblastoma is one of the highest incidence solid tumors of childhood. Therapy for neuroblastoma with MYCN proto-oncogene (MYCN) amplification is of great challenge, due to its aggressive invasion and chemoresistance. In our study, differentially expressed genes (DEGs) between MYCN-amplified and non-amplified neuroblastoma tissues were analyzed using "limma" R package. Then, DEGs were screened by silencing or enhancing expression of MYCN in neuroblastoma cells, and distal-less homeobox 5 (DLX5) was identified to be the downstream target gene. The positive correlation between DLX5 and MYCN expression was confirmed in neuroblastoma tissues and cell lines. Overall survival analysis suggested that high expression of DLX5 predicted poor clinical outcome.Then, DLX5 was demonstrated to promote proliferation and migration of neuroblastoma. Gene set enrichment analysis revealed that base excision repair and nucleotide excision repair processes were enriched in samples with DLX5 high expression. Thus, the half-maximal inhibitory concentration was measured and cisplatin treatment assay was carried out. The results revealed DLX5 promoted cisplatin chemoresistance of neuroblastoma. To explore the mechanism, mRNA sequencing was conducted and AKT signaling was suggested to be the mainly regulatory pathway, which was further verified in cells and tumor tissues. Then, we proved that heart and neural crest derivatives expressed 2, paired like homeobox 2B, GATA binding protein 3, and MYCN coregulated the expression of DLX5 at the transcriptional level, and identified the direct binding site of MYCN on DLX5 promoter. Finally, we demonstrated that DLX5 which was transcriptionally activated by MYCN, promoted growth, metastasis and chemoresistance of neuroblastoma through enhanced AKT phosphorylation. The findings in our study provided new insight for progression and chemoresistance of neuroblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Pediatric Surgical Oncology, Children's Hospital, Chongqing Medical University, Chongqing, China. Electronic address: wangshan@hospital.cqmu.edu.cn.
- Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: 2002tj0515@hust.edu.cn.
Förderung
- Tongji Hospital
- Huazhong University of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
He, Y., Yu, X., Feng, C., Chen, K., Xiao, J., Zhuansun, D., Meng, X., Wang, J., Pan, Y., Wang, Q., Zhou, B., Wang, D., Wu, L., Chen, X., Wang, S., & Feng, J. (2025). Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathway. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112183
Vancouver
He Y, Yu X, Feng C, Chen K, Xiao J, Zhuansun D, et al. Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathway. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112183
BibTeX
@article{He2025,
author = {He, Yi and Yu, Xiaosi and Feng, Chenzhao and Chen, Ke and Xiao, Jun and Zhuansun, Didi and Meng, Xinyao and Wang, Jing and Pan, Yonglong and Wang, Qiong and Zhou, Bingyan and Wang, Di and Wu, Luyao and Chen, Xuyong and Wang, Shan and Feng, Jiexiong},
title = {Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathway},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112183}
}
EUVIMED